Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Strowig: The effect of rosiglitazone on overweight subjects with type 1 diabetes. (0.08 sec) 

The effects of thiazolidinediones on blood pressure levels-a systematic review


PA Sarafidis, PM Nilsson - Blood pressure, 2006 - informahealthcare.com
Insulin resistance has been proposed to be the underlying disorder of the so‐called metabolic
or insulin resistance syndrome, which represents the clustering in the same individual of several
cardiovascular risk factors, such as type 2 diabetes mellitus, hypertension, abdominal ...
Cited by 30 - Related articles - BL Direct - All 6 versions

Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating …


YQ Zhang, XQ Tang, L Sun, L Dong, Y Qin, HQ … - WORLD JOURNAL OF …, 2007 - wjgnet.com
RESULTS: Although rosiglitazone at the concentration below 30 mmol/L for 72 h exerted almost
no inhibitory effect on proliferation and growth of HT-29 cells, it could significantly enhance
fluorouracil-induced HT-29 cell proliferation and growth inhibition. Furthermore, 10 ...
Cited by 14 - Related articles - Cached - BL Direct - All 7 versions

The effect of the PPAR ligand rosiglitazone on energy balance regulation


AMCP Joosen, AHF Bakker, MJA Gering, KR … - Diabetes/Metabolism … - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 11 - Related articles - BL Direct - All 3 versions

Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes


V Zdravkovic, JK Hamilton, D Daneman, EA … - The Journal of pediatrics, 2006 - Elsevier
Metabolic control (A1c) was improved at 6 months in all subjects (P = .02). There was no significant
difference between the pioglitazone and placebo treatment groups at 6 months in either change
in A1c (−0.4% ± 0.9% and −0.5% ± 1.2%, respectively) or insulin dose. BMI SDS ...
Cited by 11 - Related articles - All 3 versions

Role of obesity in complicating and confusing the diagnosis and treatment of …

- shouxi.net
KL Jones - Pediatrics, 2008 - Am Acad Pediatrics
The alarming increase in the prevalence of obesity in children in the United States and globally
raises major concerns about its future adverse impact on public health. One outcome of this disturbing
trend that is already evident is the rapidly increasing incidence of type 2 diabetes at all ...
Cited by 7 - Related articles - BL Direct - All 7 versions

Addressing insulin resistance in Type 1 diabetes.

- nursing2008.com
TTL Pang, P Narendran - Diabetic Medicine, 2008 - pt.wkhealth.com
Type 1 diabetes is recognised to include an element of insulin resistance. Insulin resistance
is an independent risk factor for the development of macro- and microvascular complications
of Type 1 diabetes and may also contribute to the development of the disease. This ...
Cited by 4 - Related articles - All 5 versions

Methods of measuring insulin sensitivity


KK Trout, C Homko, NC Tkacs - Biological Research For Nursing, 2007 - brn.sagepub.com
Insulin resistance is a component of several health disorders, most notably impaired glucose
tolerance and type 2 diabetes mellitus. Insulin-resistant indi- viduals have an impaired biological
response to the usual action of insulin; that is, they have reduced insulin sensitivity. ...
Cited by 4 - Related articles - BL Direct - All 2 versions

Resistência à insulina e síndrome metabólica no diabetes melito do tipo 1


SA Dib - Arq Bras Endocrinol Metab, 2006 - SciELO Brasil
A resistência à insulina (RI) pode desempenhar um papel, na história natural do diabetes melito
do tipo 1 (DM1), maior do que o habitualmente reconhecido. Nas últimas décadas, este papel
se tornou mais evidente com o aumento da obesidade e da diminuição da atividade ...
Cited by 5 - Related articles - Cached - All 3 versions

Insulin resistance and metabolic syndrome in type 1 diabetes mellitus


SA Dib - Arquivos Brasileiros de Endocrinologia & Metabologia, 2006 - SciELO Brasil
A resistência à insulina (RI) pode desempenhar um papel, na história natural do diabetes melito
do tipo 1 (DM1), maior do que o habitualmente reconhecido. Nas últimas décadas, este papel
se tornou mais evidente com o aumento da obesidade e da diminuição da atividade ...
Cited by 3 - Related articles - Cached - All 2 versions

Effect of pioglitazone therapy in lean type1 diabetes mellitus


R Bhat, A Bhansali, S Bhadada, R Sialy - Diabetes Research and Clinical …, 2007 - Elsevier
A significant improvement in post-prandial plasma glucose (PPPG) levels (9.1 ± 1.7 and 8.4 ±
1.3 mmol/L, p = 0.002) and HbA 1c (7.08 ± 0.48 and 6.86 ± 0.45%, p = 0.001) were observed
in the pioglitazone treated group, but not in the placebo treated group (8.3 ± 1.8 and 7.8 ± ...
Cited by 1 - Related articles - All 7 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google